CDK1 and cancer: Additional evidence for the antiproliferative potential of phenylpropanoids comes from studies on cinnamaldehyde and its analogs, which induced G2 arrest in human cancer cells by downregulating key G2/M regulators (CDK1, CDC25C, MAD2, CDC20).